THERAPEUTISCHE KONJUGATE

European patent · EP4031143 · In force

Register entry

Publication number
EP4031143
Application number
EP20865745
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 18, 2020
Published
Jul 27, 2022
Granted
Jul 30, 2025
Protection ends at the latest
Sep 17, 2040
Next annual fee due
Sep 30, 2027
IPC classes
A61K 31/537 (2006.01)
A61K 31/553 (2006.01)
A61K 38/10 (2006.01)
C07D 487/04 (2006.01)
C07K 19/00 (2006.01)
Priority
US 201962902554 P 19.09.2019
US 202063078055 P 14.09.2020
PCT application
PCT/US2020/051491 18.09.2020
PCT publication
WO2021/055747 25.03.2021
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Jun 11, 2026

    Change

    Published in Swissreg on 11.06.2026

  3. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  4. Jul 30, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 30.07.2025

Parties

Holder

Totus Medicines Inc.

700 Main Street, Cambridge MA 02139, US

Inventor

DHAWAN, Neil Sonin

Somerville, Massachusetts 02144, US

BLAIR, James Abellera

Arlington, Massachusetts 02474, US

PERNI, Robert B.

Marlborough, Massachusetts 01752, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.